osteosarcoma
Conditions
Interventions
Experimental group:Infusion of CIK cells
Sponsors
Department of Orthopedics, Xi nan Hospital, Third Military Medical University of Chinese PLA, Chongqing, China
Eligibility
Sex/Gender
All
Age
8 Years to 30 Years
Inclusion criteria
Inclusion criteria: 1. Aged 8 to 30 years old; Male or female; The assessmentKarnosky quality of life>60; Estimated lifetime > 3 months; 2. The pathological diagnosis of osteosarcoma; 3. Having completed surgery and new adjuvant chemotherapy treatment; 4. Recurrent pathological diagnosis, or, not pathological diagnosis, but appear the solid tumor on imaging; 5. Voluntary participants, informed consent.
Exclusion criteria
Exclusion criteria: 1. With serious complications of heart, liver, kidney, lung and so on; 2. with HIV infection or drug addicts; 3. Pregnant or lactating women; 4. untolerated side effects occurred; 5. History of allergies to biological products.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Survival time; | — |
Countries
China
Contacts
Public ContactXuquan Wang
Outcome results
None listed